Nick Haggar, recently co-chaired the Roundtable on Health and Pharmaceuticals at the 5th EU-Africa Business Forum.
In this video, we talk with Frank Bouisset, a leader of the Sandoz Tuberculosis business. Frank tells us about the work Sandoz is doing in India to produce high-quality, affordable Tuberculosis medicines and how Sandoz makes these medicines available to patients around the world through the World Health Organization.
In this video, we talk with Frank Bouisset, a leader of the Sandoz Tuberculosis business. Frank speaks about the challenges patients and healthcare systems face in fighting TB, including cost, access to quality medicines, and patient adherence to treatment.
An increase of a tenth to US$2.53 billion in turnover from emerging growth markets enabled Sandoz to raise its total turnover by 5% to US$9.16 billion last year, Generics Bulletin reported in a recent article.
This site is intended for a global audience